AI assistant
Sending…
Centessa Pharmaceuticals plc — Director's Dealing 2021
Jun 4, 2021
31309_dirs_2021-06-04_61e0f8f1-ad4d-41fd-9362-27eae44d9ccc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2021-06-02
Reporting Person: HUSSAIN IQBAL J (General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-02 | Ordinary Shares | P | 3000 | $20.00 | Acquired | 3000 | Direct |
| 2021-06-02 | Ordinary Shares | P | 5500 | $20.00 | Acquired | 5500 | Indirect |
Footnotes
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
More from Centessa Pharmaceuticals plc
M&A Activity
2026
May 22
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Share Issue/Capital Change
2026
Mar 31
M&A Activity
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 18